Glia disease and repair—Remyelination

Cold Spring Harbor Perspectives in Biology

Volumn 7, Issue 7, 2015, Pages 1-28

  Franklin, Robin J M ^a   Goldman, Steven A ^b,c  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

MAMMALIA;

ANIMAL; CELL DIFFERENTIATION; GLIA; HUMAN; METABOLISM; MOUSE; MYELIN SHEATH; NERVE REGENERATION; NEURODEGENERATIVE DISEASES; OLIGODENDROGLIA; PATHOLOGY; PHYSIOLOGY; PLURIPOTENT STEM CELL; SIGNAL TRANSDUCTION; STEM CELL TRANSPLANTATION; TRANSPLANTATION;

ANIMALS; CELL DIFFERENTIATION; HUMANS; MICE; MYELIN SHEATH; NERVE REGENERATION; NEURODEGENERATIVE DISEASES; NEUROGLIA; OLIGODENDROGLIA; PLURIPOTENT STEM CELLS; SIGNAL TRANSDUCTION; STEM CELL TRANSPLANTATION;

EID: 84936774588     PISSN: None     EISSN: 19430264     Source Type: Journal    
DOI: 10.1101/cshperspect.a020594     Document Type: Article

References (195)

1. Albert M, Antel J, Bruck W, Stadelmann C. 2007. Extensive cortical remyelination in patients with chronic multiple sclerosis. Brain Pathol 17: 129-138.
2. Altucci L, Leibowitz MD, Ogilvie KM, de Lera AR, Gronemeyer H. 2007. RAR and RXR modulation in cancer and metabolic disease. Nat Rev Drug Discov 6: 793-810.
3. Armstrong RC, Le TQ, Frost EE, Borke RC, Vana AC. 2002. Absence of fibroblast growth factor 2 promotes oligodendroglial repopulation of demyelinated white matter. J Neurosci 22: 8574-8585.
4. Armstrong RC, Le TQ, Flint NC, Vana AC, Zhou YX. 2006. Endogenous cell repair of chronic demyelination. J Neuropathol Exp Neurol 65: 245-256.
5. Arnett HA, Mason J,Marino M, Suzuki K, Matsushima GK, Ting JPY. 2001. TNFα promotes proliferation of oligodendrocyte progenitors and remyelination. Nat Neurosci 4: 1116-1122.
6. Arnett HA, Wang Y, Matsushima GK, Suzuki K, Ting JP. 2003. Functional genomic analysis of remyelination reveals importance of inflammation in oligodendrocyte regeneration. J Neurosci 23: 9824-9832.
7. Arnett HA, Fancy SPJ, Alberta JA, Zhao C, Plant SR, Raine CS, Rowitch DH, Franklin RJM, Stiles CD. 2004. The bHLH transcription factor Olig1 is required for repair of demyelinated lesions in the CNS. Science 306: 2111- 2115.
8. Back SA, Rivkees SA. 2004. Emerging concepts in periventricular white matter injury. Semin Perinatol 28: 405- 414.
9. Back SA, Tuohy TM, Chen H,Wallingford N, Craig A, Struve J, Luo NL, Banine F, Liu Y, Chang A, et al. 2005. Hyaluronan accumulates in demyelinated lesions and inhibits oligodendrocyte progenitor maturation. Nat Med 11: 966-972.
10. Baer AS, Syed YA, Kang SU, Mitteregger D, Vig R, Ffrench-Constant C, Franklin RJM, Altmann F, Lubec G, Kotter MR. 2009. Myelin-mediated inhibition of oligodendrocyte precursor differentiation can be overcome by pharmacological modulation of Fyn-RhoA and protein kinase C signalling. Brain 132: 465-481.
11. Belachew S, Chittajallu R, Aguirre AA, Yuan X, Kirby M, Anderson S, Gallo V. 2003. Postnatal NG2 proteoglycan- expressing progenitor cells are intrinsically multipotent and generate functional neurons. J Cell Biol 161: 169- 186.
12. Blakemore WF. 1975. Remyelination by Schwann cells of axons demyelinated by intraspinal injection of 6-aminonicotinamide in the rat. J Neurocytol 4: 745-757.
13. Blakemore WF, Franklin RJM. 2008. Remyelination in experimental models of toxin-induced demyelination. Curr Top Microbiol Immunol 318: 193-212.
14. Brenner M, Johnson AB, Boespflug-TanguyO, RodriguezD, Goldman JE, Messing A. 2001. Mutations in GFAP, encoding glial fibrillary acidic protein, are associated with Alexander disease. Nat Genet 27: 117-120.
15. Brinkmann BG, Agarwal A, Serada MW, Garratt AN, Mueller T, Wende H, Stassart RM, Nawaz S, Humml C, Velanac V, et al. 2008. Neuregulin-1/ErbB signaling serves distinct functions in myelination of the peripheral and central nervous system. Neuron 59: 581-594.
16. Brustle O, Jones KN, Learish RD, Karram K, Choudhary K, Wiestler OD, Duncan ID,McKay RDG. 1999. Embryonic stem cell-derived glial precursors: A source of myelinating transplants. Science 285: 754-756.
17. + glial cell proliferation and oligodendrocyte generation in the hypomyelinating mutant shiverer. Glia 48: 51-63.
18. Bugiani M, Boor I, van Kollenburg B, Postma N, Polder E, van Berkel C, van Kesteren RE, Windrem MS, Hol EM, Scheper GC, et al. 2011. Defective glial maturation in vanishing white matter disease. J Neuropathol Exp Neurol 70: 69-82.
19. Caillava C, Vandenbosch R, Jablonska B, Deboux C, Spigoni G, Gallo V,Malgrange B, Baron-Van Evercooren A. 2011. Cdk2 loss accelerates precursor differentiation and remyelination in the adult central nervous system. J Cell Biol 193: 397-407.
20. Cannella B, Hoban CJ, Gao YL, Garcia-Arenas R, Lawson D, Marchionni M, Gwynne D, Raine CS. 1998. The neuregulin, glial growth factor 2, diminishes autoimmune demyelination and enhances remyelination in a chronic relapsing model for multiple sclerosis. Proc Natl Acad Sci 95: 10100-10105.
21. Chang A, Nishiyama A, Peterson J, Prineas J, Trapp BD. 2000. NG2-positive oligodendrocyte progenitor cells in adult human brain and multiple sclerosis lesions. J Neurosci 20: 6404-6412.
22. Chang A, TourtellotteWW, Rudick R, Trapp BD. 2002. Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis. N Engl J Med 346: 165-173.
23. Chari DM, Blakemore WF. 2002. Efficient recolonisation of progenitor-depleted areas of the CNS by adult oligodendrocyte progenitor cells. Glia 37: 307-313.
24. Chari DM, Crang AJ, BlakemoreWF. 2003. Decline in rate of colonization of oligodendrocyte progenitor cell (OPC)- depleted tissue by adult OPCswith age. JNeuropathol Exp Neurol 62: 908-916.
25. Charles P, Hernandez MP, Stankoff B, Aigrot MS, Colin C, Rougon G, Zalc B, Lubetzki C. 2000. Negative regulation of central nervous system myelination by polysialylatedneural cell adhesion molecule. Proc Natl Acad Sci 97: 7585-7590.
26. Charles P, Reynolds R, Seilhean D, Rougon G, Aigrot MS, Niezgoda A, Zalc B, Lubetzki C. 2002. Re-expression of PSA-NCAM by demyelinated axons: An inhibitor or remyelination in multiple sclerosis? Brain 125: 1972-1979.
27. Conboy IM, Conboy MJ, Wagers AJ, Girma ER, Weissman IL, Rando TA. 2005. Rejuvenation of aged progenitor cells by exposure to a young systemic environment. Nature 433: 760-764.
28. Crawford AH, Stockley JH, Tripathi RB, Richardson WD, Franklin RJM. 2014. Oligodendrocyte progenitors: Adult stem cells of the central nervous system? Exp Neurol 260: 50-55.
29. Crockett DP, Burshteyn M, Garcia C, Muggironi M, Casaccia-Bonnefil P. 2005. Number of oligodendrocyte progenitors recruited to the lesioned spinal cord is modulated by the levels of the cell cycle regulatory protein p27Kip-1. Glia 49: 301-308.
30. Czepiel M, Balasubramaniyan V, Schaafsma W, Stancic M, Mikkers H, Huisman C, Boddeke E, Copray S. 2011. Differentiation of induced pluripotent stem cells into functional oligodendrocytes. Glia 59: 882-892.
31. Dawson MRL, Polito A, Levine JM, Reynolds R. 2003. NG2- expressing glial progenitor cells: An abundant and widespread population of cycling cells in the adult rat CNS. Mol Cell Neurosci 24: 476-488.
32. Deshmukh VA, Tardif V, Lyssiotis CA, Green CC, Kerman B, Kim HJ, Padmanabhan K, Swoboda JG, Ahmad I, Kondo T, et al. 2013. A regenerative approach to the treatment of multiple sclerosis. Nature 502: 327-332.
33. + glial precursor cells from cryopreserved human fetal brain progenitor cells. Glia 40: 65-77.
34. + astrocyte generation in vanishing white matter leukodystrophy. Nat Med 11: 277-283.
35. Duncan ID, Hoffman RL. 1997. Schwann cell invasion of the central nervous system of the myelin mutants. J Anatomy 190: 35-49.
36. Duncan ID, Brower A, Kondo Y, Curlee JF Jr, Schultz RD. 2009. Extensive remyelination of the CNS leads to functional recovery. Proc Natl Acad Sci 106: 6832-6836.
37. Dusart I, Marty S, Peschanski M. 1992. Demyelination and remyelination by Schwann cells and oligodendrocytes after kainate-induced neuronal depletion in the central nervous system. Neuroscience 5: 137-148.
38. Edgar JM, McLaughlin M, Yool D, Zhang SC, Fowler JH, Montague P, Barrie JA,McCulloch MC, Duncan ID, Garbern J, et al. 2004. Oligodendroglial modulation of fast axonal transport in a mouse model of hereditary spastic paraplegia. J Cell Biol 166: 121-131.
39. Einstein O, Ben-Hur T. 2008. The changing face of neural stem cell therapy in neurologic diseases. Arch Neurol 65: 452-456.
40. Escolar ML, PoeMD, Provenzale JM, Richards KC, Allison J, Wood S,Wenger DA, Pietryga D,Wall D, Champagne M, et al. 2005. Transplantation of umbilical-cord blood in babies with infantile Krabbe's disease. N Engl J Med 352: 2069-2081.
41. Etxeberria A, Mangin JM, Aguirre A, Gallo V. 2010. Adultborn SVZ progenitors receive transient synapses during remyelination in corpus callosum. Nat Neurosci 13: 287- 289.
42. Fancy SPJ, Zhao C, Franklin RJM. 2004. Increased expression of Nkx2.2 and Olig2 identifies reactive oligodendrocyte progenitor cells responding to demyelination in the adult CNS. Mol Cell Neurosci 27: 247-254.
43. Fancy SPJ, Baranzini SE, Zhao C, Yuk DI, Irvine KA, Kaing S, Sanai N, Franklin RJM, Rowitch DH. 2009. Dysregulation of the Wnt pathway inhibits timely myelination and remyelination in the mammalian CNS. Genes Dev 23: 1571-1585.
44. Fancy SPJ, Kotter MR, Harrington EP, Huang JK, Zhao C, Rowitch DH, Franklin RJM. 2010. Overcoming remyelination failure in multiple sclerosis and other myelin disorders. Exp Neurol 225: 18-23.
45. Fancy SPJ, Chan JR, Baranzini SE, Franklin RJM, Rowitch DH. 2011a. Myelin regeneration: A recapitulation of development? Annu Rev Neurosci 34: 19-41.
46. Fancy SPJ, Harrington EP, Yuen TJ, Silbereis JC, Zhao C, Baranzini SE, Bruce CC, Otero JJ, Huang EJ, Nusse R, et al. 2011b. Axin2 as regulatory and therapeutic target in newborn brain injury and remyelination. Nat Neurosci 14: 1009-1016.
47. Felts PA, Woolston AM, Fernando HB, Asquith S, Gregson NA, Mizzi OJ, Smith KJ. 2005. Inflammation and primary demyelination induced by the intraspinal injection of lipopolysaccharide. Brain 128: 1649-1666.
48. Flores AI, Narayanan SP, Morse EN, Shick HE, Yin X, Kidd G, Avila RL, Kirschner DA, Macklin WB. 2008. Constitutively active Akt induces enhanced myelination in the CNS. J Neurosci 28: 7174-7183.
49. Follett PL, DengW, DaiW, Talos DM, Massillon LJ, Rosenberg PA, Volpe JJ, Jensen FE. 2004. Glutamate receptormediated oligodendrocyte toxicity in periventricular leukomalacia: A protective role for topiramate. J Neurosci 24: 4412-4420.
50. Franklin RJM. 2002. Why does remyelination fail in multiple sclerosis? Nat Rev Neurosci 3: 705-714.
51. Franklin RJM, Blakemore WF. 1993. Requirements for Schwann cell migration within CNS environments: A viewpoint. Int J Dev Neurosci 11: 641-649.
52. Franklin RJM, Ffrench-Constant C. 2008. Remyelination in the CNS: From biology to therapy. Nat Rev Neurosci 9: 839-855.
53. Franklin RJM, Gallo V. 2014. The translational biology of remyelination: Past, present, and future. Glia doi: 10.1002/glia.22622.
54. Franklin RJM, Hinks GL. 1999. Understanding CNS remyelination: Clues from developmental and regeneration biology. J Neurosci Res 58: 207-213.
55. Franklin RJM, Kotter MR. 2008. The biology of CNS remyelination: The key to therapeutic advances. J Neurol 255: 19-25.
56. Gadea A, Aguirre A, Haydar TF, Gallo V. 2009. Endothelin-1 regulates oligodendrocyte development. J Neurosci 29: 10047-10062.
57. Gaj T, Gersbach CA, Barbas CF III. 2013. ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering. Trends Biotechnol 31: 397-405.
58. Garbern JY, Yool DA,Moore GJ,Wilds IB, FaulkMW, Klugmann M, Nave KA, Sistermans EA, van der Knaap MS, Bird TD, et al. 2002. Patients lacking the major CNS myelin protein, proteolipid protein 1, develop length-dependent axonal degeneration in the absence of demyelination and inflammation. Brain 125: 551-561.
59. Gibson EM, Purger D, Mount CW, Goldstein AK, Lin GL, Wood LS, Inema I, Miller SE, Bieri G, Zuchero JB, et al. 2014. Neuronal activity promotes oligodendrogenesis and adpative myelination in the mammalian brain. Science 344: 1252304.
60. Givogri MI, Galbiati F, Fasano S, Amadio S, Perani L, Superchi D,Morana P, Del Carro U, Marchesini S, Brambilla R, et al. 2006. Oligodendroglial progenitor cell therapy limits central neurological deficits in mice with metachromatic leukodystrophy. J Neurosci 26: 3109-3119.
61. Glezer I, Lapointe A, Rivest S. 2006. Innate immunity triggers oligodendrocyte progenitor reactivity and confines damages to brain injuries. FASEB J 20: 750-752.
62. Goldman SA. 2011. Progenitor cell-based treatment of the pediatric myelin disorders. Arch Neurol 68: 848-856.
63. Goldman SA. 2013. White matter from fibroblasts. Nat Biotechnol 31: 412-413.
64. Goldman SA, Nedergaard M, Windrem MS. 2012. Glial progenitor cell-based treatment and modeling of neurological disease. Science 338: 491-495.
65. Goldschmidt T, Antel J, Konig FB, Bruck W, Kuhlmann T. 2009. Remyelination capacity of the MS brain decreases with disease chronicity. Neurology 72: 1914-1921.
66. Griffiths I, Klugmann M, Anderson T, Yool D, Thomson C, Schwab MH, Schneider A, Zimmermann F, McCulloch M, Nadon N, et al. 1998. Axonal swellings and degeneration in mice lacking the major proteolipid of myelin. Science 280: 1610-1613.
67. Gupta N, Henry RG, Strober J, Kang SM, Lim DA, Bucci M, Caverzasi E, Gaetano L,Mandelli ML, Ryan T, et al. 2012. Neural stem cell engraftment and myelination in the human brain. Sci Transl Med 4: 155ra137.
68. Hammond TR, Gadea A, Dupree J, Kerninon C, Nait-Oumesmar B, Aguirre A, Gallo V. 2014. Astrocyte-derived endothelin-1 inhibits remyelination through Notch activation. Neuron 81: 588-602.
69. Hampton DW, Anderson J, Pryce G, Irvine KA, Giovannoni G, Fawcett JW, Compston A, Franklin RJM, Baker D, Chandran S. 2008. An experimental model of secondary progressive multiple sclerosis that shows regional variation in gliosis, remyelination, axonal and neuronal loss. J Neuro Immunol 201-202: 200-211.
70. Harrington EP, Zhao C, Fancy SPJ, Kaing S, Franklin RJM, Rowitch DH. 2010. Oligodendrocyte PTEN required for myelin and axonal integrity not remyelination. Ann Neurol 68: 703-726.
71. Hinks GL, Franklin RJM. 1999. Distinctive patterns of PDGF-A, FGF-2, IGF-I and TGF-β1 gene expression during remyelination of experimentally induced spinal cord demyelination. Mol Cell Neurosci 14: 153-168.
72. Hinks GL, Franklin RJM. 2000. Delayed changes in growth factor gene expression during slow remyelination in the CNS of aged rats. Mol Cell Neurosci 16: 542-556.
73. Horner PJ, Power AE, Kempermann G, Kuhn HG, Palmer TD,Winkler J, Thal LJ, Gage FH. 2000. Proliferation and differentiation of progenitor cells throughout the intact adult rat spinal cord. J Neurosci 20: 2218-2228.
74. Hu QD, Ang BT, Karsak M, Hu WP, Cui XY, Duka T, Takeda Y, ChiaW, Sankar N, Ng YK, et al. 2003. F3/contactin acts as a functional ligand for Notch during oligodendrocyte maturation. Cell 115: 163-175.
75. Hu BY, Du ZW, Zhang SC. 2009. Differentiation of human oligodendrocytes from pluripotent stem cells. Nat Protoc 4: 1614-1622.
76. Huang JK, Jarjour AA, Nait Oumesmar B, Kerninon C, Williams A, Krezel W, Kagechika H, Bauer J, Zhao C, Baron van Evercooren A, et al. 2011. Retinoid X receptor γ signaling accelerates CNS remyelination. Nat Neurosci 14: 45-53.
77. Hussain R, Ghoumari AM, Bielecki B, Steibel J, Boehm N, Liere P, Macklin WB, Kumar N, Habert R, Mhaouty-Kodja S, et al. 2013. The neural androgen receptor: A therapeutic target for myelin repair in chronic demyelination. Brain 136: 132-146.
78. Irvine KA, Blakemore WF. 2008. Remyelination protects axons fromdemyelination-associated axon degeneration. Brain 131: 1464-1477.
79. Itoyama Y, Webster HD, Richardson EP Jr, Trapp BD. 1983. Schwann cell remyelination of demyelinated axons in spinal cord multiple sclerosis lesions. Ann Neurol 14: 339-346.
80. Itoyama Y, Ohnishi A, Tateishi J, Kuroiwa Y, Webster HD. 1985. Spinal cord multiple sclerosis lesions in Japanese patients: Schwann cell remyelination occurs in areas that lack glial fibrillary acidic protein (GFAP). Acta Neuropathol (Berl) 65: 217-223.
81. Izrael M, Zhang P, Kaufman R, Shinder V, Ella R, Amit M, Itskovitz-Eldor J, Chebath J, Revel M. 2007. Human oligodendrocytes derived from embryonic stem cells: Effect of noggin on phenotypic differentiation in vitro and on myelination in vivo. Mol Cell Neurosci 34: 310-323.
82. Jeffery ND, Crang AJ, O'Leary MT, Hodge SJ, Blakemore WF. 1999. Behavioural consequences of oligodendrocyte progenitor cell transplantation into demyelinating lesions in rat spinal cord. Eur J Neurosci 11: 1508-1514.
83. Jeyakumar M, Dwek RA, Butters TD, Platt FM. 2005. Storage solutions: Treating lysosomal disorders of the brain. Nat Rev Neurosci 6: 713-725.
84. John GR, Shankar SL, Shafit-Zagardo B,Massimi A, Lee SC, Raine CS, Brosnan CF. 2002. Multiple sclerosis: Re-expression of a developmental pathway that restricts oligodendrocyte maturation. Nat Med 8: 1115-1121.
85. Kim K, Doi A,Wen B, Ng K, Zhao R, Cahan P, Kim J, Aryee MJ, Ji H, Ehrlich LI, et al. 2010. Epigenetic memory in induced pluripotent stem cells. Nature 467: 285-290.
86. Koc ON, Day J, Nieder M, Gerson SL, Lazarus HM,KrivitW. 2002. Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH). Bone Marrow Transplant 30: 215-222.
87. Kornek B, Storch MK, Weissert R, Wallstroem E, Stefferl A, Olsson T, Linington C, Schmidbauer M, Lassmann H. 2000. Multiple sclerosis and chronic autoimmune encephalomyelitis: A comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions. Am J Pathol 157: 267-276.
88. Kotter MR, Zhao C, van Rooijen N, Franklin RJM. 2005. Macrophage-depletion induced impairment of experimental CNS remyelination is associated with a reduced oligodendrocyte progenitor cell response and altered growth factor expression. Neurobiol Dis 18: 166-175.
89. Kotter MR, Li WW, Zhao C, Franklin RJM. 2006. Myelin impairs CNS remyelination by inhibiting oligodendrocyte precursor cell differentiation. J Neurosci 26: 328- 332.
90. Kuhlmann T, Miron V, Cui Q, Wegner C, Antel J, Bruck W. 2008. Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis. Brain 131: 1749-1758.
91. Lacorazza HD, Flax JD, Snyder EY, Jendoubi M. 1996. Expression of human β-hexosaminidase α-subunit gene (the gene defect of Tay-Sachs disease) in mouse brains upon engraftment of transduced progenitor cells. Nat Med 2: 424-429.
92. Lappe-Siefke C, Goebbels S, Gravel M, Nicksch E, Lee J, Braun PE, Griffiths IR, Nave KA. 2003. Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination. Nat Genet 33: 366-374.
93. Lasiene J, Shupe L, Perlmutter S, Horner P. 2008. No evidence for chronic demyelination in spared axons after spinal cord injury in a mouse. J Neurosci 28: 3887-3896.
94. Lee Y,Morrison BM, Li Y, Lengacher S, Farah MH, Hoffman PN, Liu Y, Tsingalia A, Jin L, Zhang P-W, et al. 2012. Oligodendroglia metabolically support axons and contribute to neurodegeneration. Nature 487: 44-448.
95. Li R, Johnson AB, Salomons G, Goldman JE,Naidu S,Quinlan R, Cree B, Ruyle SZ, Banwell B, D'Hooghe M, et al. 2005a. Glial fibrillary acidic protein mutations in infantile, juvenile, and adult forms of Alexander disease. Ann Neurol 57: 310-326.
96. Li WW, Setzu A, Zhao C, Franklin RJM. 2005b. Minocycline- mediated inhibition of microglia activation impairs oligodendrocyte progenitor cell responses and remyelination in a non-immune model of demyelination. J Neuroimmunol 158: 58-66.
97. Li WW, Penderis J, Zhao C, Schumacher M, Franklin RJM. 2006. Females remyelinate more efficiently than males following demyelination in the aged but not young adult CNS. Exp Neurol 202: 250-254.
98. Liebetanz D, Merkler D. 2006. Effects of commissural deand remyelination on motor skill behaviour in the cuprizone mouse model of multiple sclerosis. Exp Neurol 202: 217-224.
99. Lin T, Ambasudhan R, Yuan X, LiW, Hilcove S, Abujarour R, Lin X, Hahm HS, Hao E, Hayek A, et al. 2009. A chemical platform for improved induction of human iPSCs. Nat Method 6: 805-808.
100. Linington C, Engelhardt B, Kapocs G, Lassman H. 1992. Induction of persistently demyelinated lesions in the rat following the repeated adoptive transfer of encephalitogenic T cells and demyelinating antibody. J Neuroimmunol 40: 219-224.
101. Ludwin SK. 1980. Chronic demyelination inhibits remyelination in the central nervous system. Lab Invest 43: 382- 387.
102. Marin-Husstege M,Muggironi M, Liu A, Casaccia-Bonnefil P. 2002. Histone deacetylase activity is necessary for oligodendrocyte lineage progression. J Neurosci 22: 10333- 10345.
103. Mason JL, Suzuki K, Chaplin DD, Matsushima GK. 2001. Interleukin-1β promotes repair of the CNS. J Neurosci 21: 7046-7052.
104. Mason JL, Xuan S, Dragatsis I, Efstratiadis A, Goldman JE. 2003. Insulin-like growth factor (IGF) signaling through type 1 IGF receptor plays an important role in remyelination. J Neurosci 23: 7710-7718.
105. Mason JL, Toews A, Hostettler JD,Morell P, Suzuki K, Goldman JE, Matsushima GK. 2004. Oligodendrocytes and progenitors become progressively depleted within chronically demyelinated lesions. Am J Pathol 164: 1673-1682.
106. Mattis VB, Svendsen CN. 2011. Induced pluripotent stem cells: A new revolution for clinical neurology? Lancet Neurol 10: 383-394.
107. McClain CR, Sim FJ, Goldman SA. 2012. Pleiotrophin suppression of receptor protein tyrosine phosphatase-β/ζ maintains the self-renewal competence of fetal human oligodendrocyte progenitor cells. J Neurosci 32: 15066- 15075.
108. Menn B, Garcia-Verdugo JM, Yaschine C, Gonzalez-PerezO, Rowitch D, Alvarez-Buylla A. 2006. Origin of oligodendrocytes in the subventricular zone of the adult brain. J Neurosci 26: 7907-7918.
109. Merkler D, Ernsting T, Kerschensteiner M, BruckW, Stadelmann C. 2006. A new focal EAE model of cortical demyelination: Multiple sclerosis-like lesions with rapid resolution of inflammation and extensive remyelination. Brain 129: 1972-1983.
110. Mi S, Miller RH, Lee X, Scott ML, Shulag-Morskaya S, Shao Z, Chang J, Thill G, Levesque M, Zhang M, et al. 2005. LINGO-1 negatively regulates myelination by oligodendrocytes. Nat Neurosci 8: 745-751.
111. Mi S, Hu B, Hahm K, Luo Y, Kam Hui ES, Yuan Q, Wong WM, Wang L, Su H, Chu TH, et al. 2007. LINGO-1 antagonist promotes spinal cord remyelination and axonal integrity in MOG-induced experimental autoimmune encephalomyelitis. Nat Med 13: 1228-1233.
112. Michailov GV, Sereda MW, Brinkmann BG, Fischer TM, Haug B, Birchmeier C, Role L, Lai C, Schwab MH, Nave KA. 2004. Axonal neuregulin-1 regulates myelin sheath thickness. Science 304: 700-703.
113. Miron VE, Boyd A, Zhao JW, Yuen TJ, Ruckh JM, Shadrach JL, vangWijngaarden P,Wagers AJ,Williams A, Franklin RJM, et al. 2013. M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination. Nat Neurosci 16: 1211-1218.
114. Mitome M, Low HP, van deb Pol A, Nunnari JJ, Wolf MK, Billings-Gagliardi S, Schwartz WJ. 2001. Towards the recontruction of central nervous system white matter using neural precursor cells. Brain 124: 2147-2161.
115. Moore CS, Milner R, Nishiyama A, Frausto RF, Serwanski DR, Pagarigan RR, Whitton JL, Miller RH, Crocker SJ. 2011. Astrocytic tissue inhibitor of metalloproteinase-1 (TIMP-1) promotes oligodendrocyte differentiation and enhances CNS myelination. J Neurosci 31: 6247-6254.
116. Morrison BM, Lee Y, Rothstein JD. 2013. Oligodendroglia: Metabolic supporters of axons. Trends Cell Biol 23: 644- 651.
117. Murtie JC, Zhou YX, Le TQ, Vana AC, Armstrong RC. 2005. PDGF and FGF2 pathways regulate distinct oligodendrocyte lineage responses in experimental demyelination with spontaneous remyelination. Neurobiol Dis 19: 171-182.
118. Nait-Oumesmar B, Decker L, Lachapelle F, Avellana-Adalid V, Bachelin C, Van Evercooren AB. 1999. Progenitor cells of the adult mouse subventricular zone proliferate, migrate and differentiate into oligodendrocytes after demyelination. Eur J Neurosci 11: 4357-4366.
119. Najm FJ, Lager AM, Zaremba A, Wyatt K, Caprariello AV, Factor DC, Karl RT, Maeda T, Miller RH, Tesar PJ. 2013. Transcription factor-mediated reprogramming of fibroblasts to expandable, myelinogenic oligodendrocyte progenitor cells. Nat Biotechnol 31: 426-433.
120. Nave KA, Trapp BD. 2008. Axon-glial signaling and the glial support of axon function. Annu Rev Neurosci 31: 535- 561.
121. Niehaus A, Shi J, Grzenkowski M, Diers-Fenger M, Archelos J, Hartung HP, Toyka K, BruckW, Trotter J. 2000. Patients with active relapsing-remitting multiple sclerosis synthesize antibodies recognizing oligodendrocyte progenitor cell surface protein: Implications for remyelination. Ann Neurol 48: 362-371.
122. Nistor GI, Totoiu MO, Haque N, Carpenter MK, Keirstead HS. 2005. Human embryonic stem cells differentiate into oligodendrocytes in high purity and myelinate after spinal cord transplantation. Glia 49: 385-396.
123. Njenga MK,Murray PD,McGavern D, Lin X, Drescher KM, Rodriguez M. 1999. Absence of spontaneous central nervous system remyelination in class II-deficient mice infected with Theiler's virus. J Neuropathol Exp Neurol 58: 78-91.
124. Nunes MC, Roy NS, Keyoung HM, Goodman RR, McKhann G, Jiang L, Kang J, Nedergaard M, Goldman SA. 2003. Identification and isolation of multipotential neural progenitor cells from the subcortical white matter of the adult human brain. Nat Med 9: 439-447.
125. O'Leary MT, Hinks GL, Charlton HM, Franklin RJM. 2002. Increasing local levels of IGF-I mRNA expression using adenoviral vectors does not alter oligodendrocyte remyelination in the CNS of aged rats. Mol Cell Neurosci 19: 32-42.
126. Patani R, Balaratnam M, Vora A, Reynolds R. 2007. Remyelination can be extensive in multiple sclerosis despite a long disease course.Neuropathol ApplNeurobiol 33: 277- 287.
127. Patrikios P, Stadelmann C, Kutzelnigg A, Rauschka H, Schmidbauer M, Laursen H, Sorensen PS, BruckW, Lucchinetti C, Lassmann H. 2006. Remyelination is extensive in a subset of multiple sclerosis patients. Brain 129: 3165-3172.
128. Pellegatta S, Tunici P, Poliani PL, Dolcetta D, Cajola L, Colombelli C, Ciusani E, Di Donato S, Finocchiaro G. 2006. The therapeutic potential of neural stem/progenitor cells in murine globoid cell leukodystrophy is conditioned by macrophage/microglia activation. Neurobiol Dis 21: 314-323.
129. Penderis J, Shields SA, Franklin RJM. 2003a. Impaired remyelination and depletion of oligodendrocyte progenitors does not occur following repeated episodes of focal demyelination in the rat CNS. Brain 126: 1382-1391.
130. Penderis J,Woodruff RH, Lakatos A, LiWW, Dunning MD, Zhao C,Marchionni M, Franklin RJM. 2003b. Increasing local levels of neuregulin (glial growth factor-2) by direct infusion into areas of demyelination does not alter remyelination in the rat CNS. Eur J Neurosci 18: 2253- 2264.
131. Piaton G,Williams A, Seilhean D, Lubetzki C. 2009. Remyelination in multiple sclerosis. Prog Brain Res 175: 453- 464.
132. Piaton G, Aigrot MS, Williams A, Moyon S, Tepavcevic V, Moutkine I, Gras J, Matho KS, Schmitt A, Soellner H, et al. 2011. Class 3 semaphorins influence oligodendrocyte precursor recruitment and remyelination in adult central nervous system. Brain 134: 1156-1167.
133. Plant SR, Iocca HA, Wang Y, Thrash JC, O'Connor BP, Arnett HA, Fu YX, Carson MJ, Ting JP. 2007. Lymphotoxin β receptor (LtβR): Dual roles in demyelination and remyelination and successful therapeutic intervention using LtβR-Ig protein. J Neurosci 27: 7429-7437.
134. Pluchino S, Quattrini A, Brambilla E, Gritti A, Salani G, Dina G, Galli R, Del Carro U, Amadio S, Bergami A, et al. 2003. Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis. Nature 422: 688-694.
135. Pluchino S, Furlan R, Martino G. 2004. Cell-based remyelinating therapies in multiple sclerosis: Evidence from experimental studies. Curr Opin Neurol 17: 247-255.
136. PohlHB, Porcheri C,Mueggler T, Bachmann LC,Martino G, Riethmacher D, Franklin RJM, Rudin M, Suter U. 2011. Genetically induced adult oligodendrocyte cell death is associated with poor myelin clearance, reduced remyelination, and axonal damage. J Neurosci 31: 1069-1080.
137. Polo JM, Liu S, Figueroa ME, KulalertW, Eminli S, Tan KY, Apostolou E, Stadtfeld M, Li Y, Shioda T, et al. 2010. Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells. Nat Biotechnol 28: 848-855.
138. Powers BE, Sellers DL, Lovelett EA, Cheung W, Aalami SP, Zapertov N, Maris DO, Horner PJ. 2013. Remyelination reporter reveals prolonged refinement of spontaneously regenerated myelin. Proc Natl Acad Sci 110: 4075-4080.
139. Prayoonwiwat N, Rodriguez M. 1993. The potential for oligodendrocyte proliferation during demyelinating disease. J Neuropathol Exp Neurol 52: 55-63.
140. Pruszak J, Ludwig W, Blak A, Alavian K, Isacson O. 2009. CD15, CD24, and CD29 define a surface biomarker code for neural lineage differentiation of stem cells. Stem Cells 27: 2928-2940.
141. Rhodes KE, Raivich G, Fawcett JW. 2006. The injury response of oligodendrocyte precursor cells is induced by platelets, macrophages and inflammation-associated cytokines. Neuroscience 140: 87-100.
142. RichardsonWD, Young KM, Tripathi RB,McKenzie I. 2011. NG2-glia as multipotent neural stem cells: Fact or fantasy? Neuron 70: 661-673.
143. Robinson S, Petelenz K, Li Q, Cohen ML, Dechant A, Tabrizi N, Bucek M, Lust D, Miller RH. 2005. Developmental changes induced by graded prenatal systemic hypoxicischemic insults in rats. Neurobiol Dis 18: 568-581.
144. Roy NS,Wang S, Harrison-Restelli C, Benraiss A, Fraser RA, Gravel M, Braun PE, Goldman SA. 1999. Identification, isolation, and promoter-defined separation of mitotic oligodendrocyte progenitor cells from the adult human subcortical white matter. J Neurosci 19: 9986-9995.
145. Roy NS, Cleren C, Singh S, Yang L, Beal MF, Goldman SA. 2006. Functional engraftment of human ES cell-derived dopaminergic neurons enriched by co-culture with telomerase-immortalized midbrain astrocytes. Nat Med 12: 1259-1268.
146. Ruckh JM, Zhao JW, Shadrach JL, van Wijngaarden P, Rao TN, Wagers AJ, Franklin RJM. 2012. Rejuvenation of regeneration in the aging central nervous system. Cell Stem Cell 10: 96-103.
147. Setzu A, Lathia JD, Zhao C, Wells KA, Rao M, Ffrench-Constant C, Franklin RJM. 2006. Inflammation stimulates myelination by transplanted oligodendrocyte precursor cells. Glia 54: 297-303.
148. Shen S, Sandoval J, Swiss V, Li J, Dupree J, Franklin RJM, Casaccia-Bonnefil P. 2008. Age-dependent epigenetic control of differentiation inhibitors: A critical determinant of remyelination efficiency. Nat Neurosci 11: 1024- 1034.
149. Sim FJ, Zhao C, Li WW, Lakatos A, Franklin RJM. 2002a. Expression of the POU domain transcription factors SCIP/Oct-6 and Brn-2 is associated with Schwann cell but not oligodendrocyte remyelination of the CNS. Mol Cell Neurosci 20: 669-682.
150. Sim FJ, Zhao C, Penderis J, Franklin RJM. 2002b. The agerelated decrease in CNS remyelination efficiency is attributable to an impairment of both oligodendrocyte progenitor recruitment and differentiation. J Neurosci 22: 2451-2459.
151. Sim FJ, Lang JK, Waldau B, Roy NS, Schwartz TE, Pilcher WH, Chandross KJ, Natesan S, Merrill JE, Goldman SA. 2006. Complementary patterns of gene expression by human oligodendrocyte progenitors and their environment predict determinants of progenitor maintenance and differentiation. Ann Neurol 59: 763-779.
152. Sim FJ, McClain CR, Schanz SJ, Protack TL, Windrem MS, Goldman SA. 2011. CD140a identifies a population of highlymyelinogenic, migration-competent and efficiently engrafting human oligodendrocyte progenitor cells. Nat Biotechnol 29: 934-941.
153. Sloane JA, Batt C, Ma Y, Harris ZM, Trapp B, Vartanian T. 2010. Hyaluronan blocks oligodendrocyte progenitor maturation and remyelination through TLR2. Proc Natl Acad Sci 107: 11555-11560.
154. Smith KJ, Blakemore WF, McDonald WI. 1979. Central remyelination restores secure conduction. Nature 280: 395-396.
155. Snyder DH, Valsamis MP, Stone SH, Raine CS. 1975. Progressive demyelination and reparative phenomena in chronic experimental allergic encephalomyelitis. JNeuropathol Exp Neurol 34: 209-221.
156. Snyder EY, Taylor RM, Wolfe JH. 1995. Neural progenitor cell engraftment corrects lysosomal storage throughout the MPS VII mouse brain. Nature 374: 367-370.
157. Stadtfeld M, Hochedlinger K. 2010. Induced pluripotency: History, mechanisms, and applications. Genes Dev 24: 2239-2263.
158. Stadtfeld M, Apostolou E, Akutsu H, Fukuda A, Follett P, Natesan S, Kono T, Shioda T, Hochedlinger K. 2010. Aberrant silencing of imprinted genes on chromosome 12qF1 in mouse induced pluripotent stem cells. Nature 465: 175-181.
159. Stidworthy MF, Genoud S, Suter U, Mantei N, Franklin RJM. 2003. Quantifying the early stages of remyelination following cuprizone-induced demyelination. Brain Pathol 13: 329-339.
160. Stidworthy MF, Genoud S, Li WW, Leone DP, Mantei N, Suter U, Franklin RJM. 2004. Notch1 and Jagged1 are expressed after CNS demyelination but are not a major rate-determining factor during remyelination. Brain 127: 1928-1941.
161. Syed YA, Hand E, Mobius W, Zhao C, Hofer M, Nave KA, Kotter MR. 2011. Inhibition of CNS remyelination by the presence of semaphorin 3A. J Neurosci 31: 3719-3728.
162. Syed YA, Baer A, Hofer MP, Gonzalez GA, Rundle J, Myrta S, Huang JK, Zhao C, Rossner MJ, Trotter MW, et al. 2013. Inhibition of phosphodiesterase-4 promotes oligodendrocyte precursor cell differentiation and enhances CNS remyelination. EMBO Mol Med 5: 1918-1934.
163. Tamaki SJ, Jacobs Y, Dohse M, Capela A, Cooper JD, Reitsma M, He D, Tushinski R, Belichenko PV, Salehi A, et al. 2009. Neuroprotection of host cells by human central nervous system stem cells in a mouse model of infantile neuronal ceroid lipofuscinosis.Cell StemCell 5: 310-319.
164. Tang DG, Tokumoto YM, Raff MC. 2000. Long-term culture of purified postnatal oligodendrocyte precursor cells. Evidence for an intrinsic maturation program that plays out over months. J Cell Biol 148: 971-984.
165. Trapp BD, Nave KA. 2008. Multiple sclerosis: An immune or neurodegenerative disorder? Annu Rev Neurosci 31: 247-269.
166. Tripathi RB, Rivers LE, Young KM, Jamen F, Richardson WD. 2010. NG2 glia generate new oligodendrocytes but few astrocytes in a murine experimental autoimmune encephalomyelitis model of demyelinating disease. JNeurosci 30: 16383-16390.
167. Urayama A, Grubb JH, Sly WS, Banks WA. 2004. Developmentally regulated mannose 6-phosphate receptor-mediated transport of a lysosomal enzyme across the blood- brain barrier. Proc Natl Acad Sci 101: 12658-12663.
168. Vela JM,Molina-Holgado E, Arevalo-Martin A, Almazan G, Guaza C. 2002. Interleukin-1 regulates proliferation and differentiation of oligodendrocyte progenitor cells. Mol Cell Neurosci 20: 489-502.
169. Wang S, SdrullaAD, diSibio G, Bush G,NofzigerD, Hicks C, Weinmaster G, Barres BA. 1998. Notch receptor activation inhibits oligodendrocyte differentiation. Neuron 21: 63-75.
170. Wang S, Bates J, Li X, Schanz S, Chandler-MilitelloD, Levine C, Maherali N, Studer L, Hochedlinger K,Windrem M, et al. 2013. Human iPSC-derived oligodendrocyte progenitor cells can myelinate and rescue a mouse model of congenital hypomyelination. Cell Stem Cell 12: 252-264.
171. Warrington AE, Asakura K, Bieber AJ, Ciric B, Van KV, Kaveri SV, Kyle RA, Pease LR, Rodriguez M. 2000. Human monoclonal antibodies reactive to oligodendrocytes promote remyelination in a model of multiple sclerosis. Proc Natl Acad Sci 97: 6820-6825.
172. Watanabe M, Hadzic T, Nishiyama A. 2004. Transient upregulation of Nkx2.2 expression in oligodendrocyte lineage cells during remyelination. Glia 46: 311-322.
173. Werner HB, Kuhlmann K, Shen S, Uecker M, Schardt A, Dimova K, Orfaniotou F, Dhaunchak A, Brinkmann BG,MobiusW, et al. 2007. Proteolipid protein is required for transport of sirtuin 2 into CNS myelin. J Neurosci 27: 7717-7730.
174. Williams A, Piaton G, Aigrot MS, Belhadi A, Theaudin M, Petermann F, Thomas JL, Zalc B, Lubetzki C. 2007a. Semaphorin 3A and 3F: Key players in myelin repair in multiple sclerosis? Brain 130: 2554-2565.
175. Williams A, Piaton G, Lubetzki C. 2007b. Astrocytes- Friends or foes in multiple sclerosis? Glia 55: 1300-1312.
176. Windrem MS, Roy NS,Wang J,Nunes M, Benraiss A, Goodman R, McKhann GM, Goldman SA. 2002. Progenitor cells derived from the adult human subcortical white matter disperse and differentiate as oligodendrocytes within demyelinated lesions of the rat brain. J Neurosci Res 69: 966-975.
177. Windrem MS, Nunes MC, Rashbaum WK, Schwartz TH, Goodman RA,McKhann G, Roy NS, Goldman SA. 2004. Fetal and adult human oligodendrocyte progenitor cell isolates myelinate the congenitally dysmyelinated brain. Nat Med 10: 93-97.
178. Windrem MS, Schanz SJ, Guo M, Tian GF,Washco V, Stanwood N, Rasband M, Roy NS, Nedergaard M, Havton LA, et al. 2008. Neonatal chimerization with human glial progenitor cells can both remyelinate and rescue the otherwise lethally hypomyelinated shiverer mouse. Cell Stem Cell 2: 553-565.
179. Wolswijk G. 1998. Chronic stage multiple sclerosis lesions contain a relatively quiescent population of oligodendrocyte precursor cells. J Neurosci 18: 601-609.
180. Wolswijk G. 2002. Oligodendrocyte precursor cells in the demyelinated multiple sclerosis spinal cord. Brain 125: 338-349.
181. Wolswijk G, Noble M. 1989. Identification of an adult-specific glial progenitor cell. Development 105: 387-400.
182. WolswijkG,Noble M. 1992. Cooperation between PDGF and FGF converts slowly dividing O-2Aadult progenitors to rapidly dividing cells with characteristics of O-2Aperinatal progenitor cells. J Cell Biol 118: 889-900.
183. Woodruff RH, Fruttiger M, RichardsonWD, Franklin RJM. 2004. Platelet-derived growth factor regulates oligodendrocyte progenitor numbers in adult CNS and their response following CNS demyelination. Mol Cell Neurosci 25: 252-262.
184. Xin M, Yue T,Ma Z,Wu FF, Gow A, Lu QR. 2005. Myelinogenesis and axonal recognition by oligodendrocytes in brain are uncoupled in Olig1-null mice. J Neurosci 25: 1354-1365.
185. Yamanaka S. 2007. Strategies and new developments in the generation of patient-specific pluripotent stem cells. Cell Stem Cell 1: 39-49.
186. Yamanaka S. 2008. Pluripotency and nuclear reprogramming. Philos Trans R Soc B 363: 2079-2087.
187. Yandava BD, Billinghurst LL, Snyder EY. 1999. "Global" cell replacement is feasible via neural stem cell transplantation: Evidence from the dysmyelinated shiverer mouse brain. Proc Natl Acad Sci 96: 7029-7034.
188. Yang N, Zuchero JB, Ahlenius H, Marro S, Ng YH, Vierbuchen T, Hawkins JS, Geissler R, Barres BA, Wernig M. 2013. Generation of oligodendroglial cells by direct lineage conversion. Nat Biotechnol 31: 434-439.
189. Yao DL, Liu X, Hudson LD, Webster Hd. 1995. Insulin-like growth factor I treatment reduces demyelination and upregulates gene expression of myelin-related proteins in experimental autoimmune encephalomyelitis. Proc Natl Acad Sci 92: 6190-6194.
190. Ye F, Chen Y,Hoang T,Montgomery RL, Zhao XH, Bu H,Hu T, Taketo MM, van Es JH, Clevers H, et al. 2009. HDAC1 and HDAC2 regulate oligodendrocyte differentiation by disrupting the β-catenin-TCF interaction. Nat Neurosci 12: 829-838.
191. Yuen TJ, Johnson KR, Miron VE, Zhao C, Quandt J, Harrisingh MC, McFarland HF, Franklin RJM, Ffrench-Constant C. 2013. Identification of endothelin-2 as an inflammatory factor that promotes CNS remyelination. Brain 136: 1035-1047.
192. Zawadzka M, Rivers LE, Fancy SPJ, Zhao C, Tripathi R, Jamen F, Young K, Goncharevich A, Pohl H, Rizzi M, et al. 2010. CNS-resident glial progenitor/stem cells produce Schwann cells aswell as oligodendrocytes during repair of CNS demyelination. Cell Stem Cell 6: 578-590.
193. Zhang SC, Wernig M, Duncan ID, Brustle O, Thomson JA. 2001. In vitro differentiation of transplantable neural precursors from human embryonic stem cells. Nat Biotechnol 19: 1129-1133.
194. Zhang Y, Argaw AT, Gurfein BT, Zameer A, Snyder BJ, Ge C, Lu QR, Rowitch DH, Raine CS, Brosnan CF, et al. 2009. Notch1 signaling plays a role in regulating precursor differentiation during CNS remyelination. Proc Natl Acad Sci 106: 19162-19167.
195. Zhao C, LiWW, Franklin RJM. 2006. Differences in the early inflammatory responses to toxin-induced demyelination are associated with the age-related decline in CNS remyelination. Neurobiol Aging 27: 1298-1307.